U.S., Jan. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07360106) titled 'Efficacy of Symprove Probiotics in Coeliac Disease' on Jan. 14.
Brief Summary: Coeliac Disease (CD) is a lifelong autoimmune condition where eating gluten (a protein found in wheat, barley, and rye) causes damage to the small intestine. It affects around 1 in 100 people. Most individuals feel better and their gut heals after switching to a strict gluten-free diet. However, up to 1 in 5 people with coeliac disease continue to experience unpleasant gut symptoms-such as bloating, pain, and diarrhoea-despite following the diet and having a healed intestine. These ongoing symptoms can be very distressing and impact daily life.
This stud...